Cargando…
Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice
Accumulating evidence indicates that the increased burden of senescent cells (SCs) in aged organisms plays an important role in many age-associated diseases. The pharmacological elimination of SCs with “senolytics” has been emerging as a new therapy for age-related diseases and extending the healthy...
Autores principales: | Zhang, Yanghuan, Gao, Dongxiao, Yuan, Yang, Zheng, Runzi, Sun, Manting, Jia, Shuting, Liu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095196/ https://www.ncbi.nlm.nih.gov/pubmed/37047529 http://dx.doi.org/10.3390/ijms24076554 |
Ejemplares similares
-
The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies
por: Liu, Jiahua, et al.
Publicado: (2023) -
Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020) -
Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development
por: Hu, Li, et al.
Publicado: (2022) -
Targeting anxiety and senescence with senolytics
por: Raffaele, Marco, et al.
Publicado: (2022) -
The Complement System, Aging, and Aging-Related Diseases
por: Zheng, Runzi, et al.
Publicado: (2022)